Edition:
United States

Sunesis Pharmaceuticals Inc Q3 loss per share ‍$0.43​


Thursday, 2 Nov 2017 07:00am EDT 

Nov 2 (Reuters) - Sunesis Pharmaceuticals Inc :Sunesis Pharmaceuticals reports third quarter 2017 financial results and recent highlights.Sunesis Pharmaceuticals Inc qtrly loss per share ‍$0.43​.Sunesis Pharmaceuticals Inc- ‍pro-forma Sept 30, 2017 cash, cash equivalents and marketable securities of $37.1 million is expected to fund co into 2019​. 

Company Quote

1.23
-0.02 -1.60%
16 Nov 2018